Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leila Dorling

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2014
Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with PaclitaxelJean E Abraham, Qi Guo, Leila Dorling, et al.
British Journal of Cancer|April 13, 2016
Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicityMahbubl Ahmed, Leila Dorling, Sarah Kerns, et al.
Cancer Research|November 3, 2018
Differential Burden of Rare and Common Variants on Tumor Characteristics, Survival, and Mode of Detection in Breast CancerJingmei Li, Emilio Ugalde-Morales, Wei Xiong Wen, et al.
The Journal of Pathology|November 30, 2021
Splicing predictions, minigene analyses, and ACMG-AMP clinical classification of 42 germline PALB2 splice-site variantsAlberto Valenzuela-Palomo, Elena Bueno-Martínez, Lara Sanoguera-Miralles, et al.
International Journal of Cancer|September 4, 2018
Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohortJingmei Li, Wei Xiong Wen, Martin Eklund, et al.
American Journal of Human Genetics|October 7, 2022
Segregation analysis of 17,425 population-based breast cancer families: Evidence for genetic susceptibility and risk predictionShuai Li, Robert J MacInnis, Andrew Lee, et al.
Nature Genetics|July 1, 2014
A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1Laura Fachal, Antonio Gómez-Caamaño, Gillian C Barnett, et al.
Journal of Medical Genetics|October 11, 2017
Inherited mutations in <i>BRCA1</i> and <i>BRCA2</i> in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from MalaysiaWei Xiong Wen, Jamie Allen, Kah Nyin Lai, et al.
Ebiomedicine|August 13, 2016
Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate CancerSarah L Kerns, Leila Dorling, Laura Fachal, et al.
Familial Cancer|June 14, 2021
First international workshop of the ATM and cancer risk group (4-5 December 2019)Fabienne Lesueur, Douglas F Easton, Anne-Laure Renault, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2014
Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with PaclitaxelJean E Abraham, Qi Guo, Leila Dorling, et al.
British Journal of Cancer|April 13, 2016
Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicityMahbubl Ahmed, Leila Dorling, Sarah Kerns, et al.
Cancer Research|November 3, 2018
Differential Burden of Rare and Common Variants on Tumor Characteristics, Survival, and Mode of Detection in Breast CancerJingmei Li, Emilio Ugalde-Morales, Wei Xiong Wen, et al.
The Journal of Pathology|November 30, 2021
Splicing predictions, minigene analyses, and ACMG-AMP clinical classification of 42 germline PALB2 splice-site variantsAlberto Valenzuela-Palomo, Elena Bueno-Martínez, Lara Sanoguera-Miralles, et al.
International Journal of Cancer|September 4, 2018
Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohortJingmei Li, Wei Xiong Wen, Martin Eklund, et al.
American Journal of Human Genetics|October 7, 2022
Segregation analysis of 17,425 population-based breast cancer families: Evidence for genetic susceptibility and risk predictionShuai Li, Robert J MacInnis, Andrew Lee, et al.
Nature Genetics|July 1, 2014
A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1Laura Fachal, Antonio Gómez-Caamaño, Gillian C Barnett, et al.
Journal of Medical Genetics|October 11, 2017
Inherited mutations in <i>BRCA1</i> and <i>BRCA2</i> in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from MalaysiaWei Xiong Wen, Jamie Allen, Kah Nyin Lai, et al.
Ebiomedicine|August 13, 2016
Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate CancerSarah L Kerns, Leila Dorling, Laura Fachal, et al.
Familial Cancer|June 14, 2021
First international workshop of the ATM and cancer risk group (4-5 December 2019)Fabienne Lesueur, Douglas F Easton, Anne-Laure Renault, et al.
Pageof 4